Comparing Codexis (CDXS) and LyondellBasell (LYB)

Codexis (NASDAQ: CDXS) and LyondellBasell (NYSE:LYB) are both industrial products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Codexis and LyondellBasell, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Codexis 0 0 3 0 3.00
LyondellBasell 0 7 9 0 2.56

Codexis currently has a consensus target price of $13.00, suggesting a potential downside of 6.47%. LyondellBasell has a consensus target price of $116.21, suggesting a potential upside of 2.15%. Given LyondellBasell’s higher possible upside, analysts clearly believe LyondellBasell is more favorable than Codexis.

Earnings & Valuation

This table compares Codexis and LyondellBasell’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Codexis $50.02 million 14.79 -$22.99 million ($0.50) -27.80
LyondellBasell $34.48 billion 1.29 $4.88 billion $10.23 11.12

LyondellBasell has higher revenue and earnings than Codexis. Codexis is trading at a lower price-to-earnings ratio than LyondellBasell, indicating that it is currently the more affordable of the two stocks.


This table compares Codexis and LyondellBasell’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Codexis -36.06% -87.65% -42.15%
LyondellBasell 14.83% 53.55% 17.18%

Volatility and Risk

Codexis has a beta of -1.71, suggesting that its stock price is 271% less volatile than the S&P 500. Comparatively, LyondellBasell has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Institutional & Insider Ownership

64.8% of Codexis shares are held by institutional investors. Comparatively, 73.6% of LyondellBasell shares are held by institutional investors. 11.4% of Codexis shares are held by insiders. Comparatively, 0.1% of LyondellBasell shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.


LyondellBasell pays an annual dividend of $4.00 per share and has a dividend yield of 3.5%. Codexis does not pay a dividend. LyondellBasell pays out 39.1% of its earnings in the form of a dividend. LyondellBasell has raised its dividend for 6 consecutive years.


LyondellBasell beats Codexis on 13 of the 17 factors compared between the two stocks.

About Codexis

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

About LyondellBasell

LyondellBasell Industries N.V. is a chemical company. The Company operates in five segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Refining and Technology. The O&P-Americas segment produces and markets olefins and co-products, polyethylene and polypropylene. The O&P-EAI segment produces and markets olefins and co-products, polyethylene and polypropylene. The I&D segment produces and markets propylene oxide (PO) and its derivatives, oxyfuels and related products, and intermediate chemicals, such as styrene monomer (SM), acetyls and ethylene oxides. The primary product of the Refining segment is refined products made from sulfur crude oil and other crude oils of various types and sources available on the United States Gulf Coast. The Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.

Receive News & Ratings for Codexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Codexis and related companies with's FREE daily email newsletter.

Leave a Reply